Home » Topics » Regulatory

Regulatory
RSS

Smoking cessation treatment launched in the U.S.

July 10, 1997

New clinical uses of risperidone investigated

July 10, 1997

Nefazodone evaluated for social phobia

July 10, 1997

Preclinical and clinical antidepressant properties of tolcapone

July 10, 1997

Promising preliminary results from open trial of lamotrigine in depression

July 9, 1997

NKH-477 possesses antidepressant effects

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Dovonex cleared for use in children in the U.K.

July 9, 1997

Losec available in U.K. for symptoms of dyspepsia

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...